Stockholders’ Equity |
6 Months Ended | ||
---|---|---|---|
Jun. 30, 2021 | |||
Equity [Abstract] | |||
Stockholders’ Equity |
Warrants
In connection with certain of the Company’s collaboration agreements and consulting arrangements, the Company has issued warrants to purchase shares of common stock as payment for services. As of June 30, 2021 and December 31, 2020, collaboration warrants to purchase 0 and 30,307 shares of common stock were outstanding. collaboration warrants were granted or exercised in connection with collaboration or consulting services during the three and six months ended June 30, 2021. Collaboration warrants to purchase shares expired during the three and six months ended June 30, 2021. collaboration warrants were granted or exercised and expired in connection with collaboration or consulting services during the three and six months ended June 30, 2020, respectively.
In addition, the Company has outstanding warrants to purchase an aggregate of 347,505 and 378,453 shares of common stock in connection with debt and equity financing arrangements as of June 30, 2021 and December 31, 2020, respectively. As of June 30, 2021, these warrants have an average weighted exercise price of $ per share and expiration dates ranging from July 2021 through September 2026. debt and equity financing warrants were granted during the three and six months ended June 30, 2021 and 2020. During the six months ended June 30, 2021 and 2020, debt and equity financing warrants to purchase approximately and million shares of common stock, respectively, were exercised on a cashless one-for-one basis. debt and equity financing warrants were exercised during the three months ended June 30, 2021 and 2020, respectively. In addition, approximately and debt and equity warrants expired during the three and six months ended June 30, 2021. debt and equity warrants expired during the three and six months ended June 30, 2020. |